Kseniya Simpson - Profile and Investment Details

Investor Profile

Kseniya Simpson is a Venture Capital, Private Equity Firm, Investor based in North Carolina, United States with a diverse investment portfolio that includes companies such as Standard Bariatrics, Contego Medical, Clearside Biomedical, Vigil Neuroscience, Artizan Biosciences, MATI Energy, SpineAlign Medical, Code Biotherapeutics, Lysosomal TherapeuticsKymera Therapeutics, Spyryx Biosciences, Bivarus, North Carolina Biosciences Organization (NCBIO), AtaCor Medical, Sensorium Therapeutics, Jumo Health, Clinipace, StrideBio, GrayBug, Nusirt, WalletFi, Ribometrix, Curoverse, Ten63 Therapeutics, Rodin Therapeutics, Aer Therapeutics, Inc., Medfusion, GeneCentric Diagnostics, Boragen, Myeloid Therapeutics, Trefoil Therapeutics, Empliant, G1 Therapeutics, ArtusLabs, Clinverse, Elligo Health Research, Atsena Therapeutics, PhaseBio Pharmaceuticals, HistoSonics, Ribometrix Inc., Boston Immune Technologies & Therapeutics, NeuroTronik, Altis Biosystems, Viamet Pharmaceuticals, Coferon, TetraLogic Pharmaceuticals, ORIG3N, 410 Medical, CVRx, Qpex Biopharma, Qvella Corporation, NurseGrid, Sideris Pharmaceuticals, Wildflower Health, Shattuck Labs, . Over time, Kseniya Simpson has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Kseniya Simpson is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Regenerative Medicine, Wellness, Women Founded, Android, Healthcare Innovation, Life Science, Medical Technologies, Information Technology (IT), Software, Biotechnology, Healthcare IT, Medical Devices, Drug Development, Precision Medicine, Clinical Trials, Gene Therapy, Personalized Medicine, Medical Diagnostics, Health Diagnostics, Digital Health, Medical, B2B, Therapeutics, Media and Entertainment, Pharmaceuticals may find it worthwhile to explore potential connections with Kseniya Simpson, as their portfolio suggests a familiarity and interest in this area.

Understanding Kseniya Simpson’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.